Zhenwu Li

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bicyclic amines as CDK2 inhibitors
- Patent number 11,851,426
- Issue date Dec 26, 2023
- Incyte Corporation
- Yingda Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic heterocyclic compounds as sting activators
- Patent number 11,713,317
- Issue date Aug 1, 2023
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,608,337
- Issue date Mar 21, 2023
- Incyte Corporation
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-L1/STING conjugates and methods of use
- Patent number 11,596,692
- Issue date Mar 7, 2023
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
- Patent number 11,472,791
- Issue date Oct 18, 2022
- Incyte Corporation
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,407,749
- Issue date Aug 9, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as LSD1 inhibitors
- Patent number 11,401,272
- Issue date Aug 2, 2022
- Incyte Corporation
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic heterocyclic compounds as sting activators
- Patent number 10,947,227
- Issue date Mar 16, 2021
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as LSD1 inhibitors
- Patent number 10,800,779
- Issue date Oct 13, 2020
- Incyte Corporation
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as LSD1 inhibitors
- Patent number 9,944,647
- Issue date Apr 17, 2018
- Incyte Corporation
- Chunhong He
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BICYCLIC AMINES AS CDK2 INHIBITORS
- Publication number 20240174664
- Publication date May 30, 2024
- INCYTE CORPORATION
- Yingda Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-L1/STING CONJUGATES AND METHODS OF USE
- Publication number 20230398225
- Publication date Dec 14, 2023
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20230226062
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20230192689
- Publication date Jun 22, 2023
- INCYTE CORPORATION
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230114765
- Publication date Apr 13, 2023
- INCYTE CORPORATION
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220213090
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220194931
- Publication date Jun 23, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC HETEROCYCLIC COMPOUNDS AS STING ACTIVATORS
- Publication number 20220073509
- Publication date Mar 10, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210347771
- Publication date Nov 11, 2021
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20210269434
- Publication date Sep 2, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210107900
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC AMINES AS CDK2 INHIBITORS
- Publication number 20210107901
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Yingda Ye
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210017175
- Publication date Jan 21, 2021
- INCYTE CORPORATION
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS
- Publication number 20210017156
- Publication date Jan 21, 2021
- INCYTE CORPORATION
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20200392143
- Publication date Dec 17, 2020
- INCYTE CORPORATION
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20200172541
- Publication date Jun 4, 2020
- INCYTE CORPORATION
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC HETEROCYCLIC COMPOUNDS AS STING ACTIVATORS
- Publication number 20190359608
- Publication date Nov 28, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20190225601
- Publication date Jul 25, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20190144439
- Publication date May 16, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20190071439
- Publication date Mar 7, 2019
- INCYTE CORPORATION
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20190055250
- Publication date Feb 21, 2019
- INCYTE CORPORATION
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180179197
- Publication date Jun 28, 2018
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180177784
- Publication date Jun 28, 2018
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180179202
- Publication date Jun 28, 2018
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20170320875
- Publication date Nov 9, 2017
- INCYTE CORPORATION
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20170107216
- Publication date Apr 20, 2017
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20160289238
- Publication date Oct 6, 2016
- INCYTE CORPORATION
- Chunhong He
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Bicyclic amines as CDK2 inhibitors

Tricyclic heterocyclic compounds as sting activators

Heterocyclic compounds as immunomodulators

PD-L1/STING conjugates and methods of use

Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors

Heterocyclic compounds as immunomodulators

Heterocyclic compounds as LSD1 inhibitors

Tricyclic heterocyclic compounds as sting activators

Heterocyclic compounds as LSD1 inhibitors

Heterocyclic compounds as LSD1 inhibitors

Patents Applicationslast 30 patents

BICYCLIC AMINES AS CDK2 INHIBITORS

PD-L1/STING CONJUGATES AND METHODS OF USE

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

TRICYCLIC HETEROCYCLIC COMPOUNDS AS STING ACTIVATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

BICYCLIC AMINES AS CDK2 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

PYRAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS

HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

TRICYCLIC HETEROCYCLIC COMPOUNDS AS STING ACTIVATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS